MDI board rejects Raytel tender offer
Imaging services firm Raytel'stender offer for Medical Diagnostics has been rejected by MDI'sboard of directors. MDI has also filed suit against Raytel andimplemented a stockholders' rights package to derail Raytel'sbid. Raytel, of San Mateo, CA,
Imaging services firm Raytel'stender offer for Medical Diagnostics has been rejected by MDI'sboard of directors. MDI has also filed suit against Raytel andimplemented a stockholders' rights package to derail Raytel'sbid.
Raytel, of San Mateo, CA, announced last month that it was preparingto launch a tender offer for all outstanding shares of MDI, ofBurlington, MA (SCAN 12/14/94). On Dec. 16, MDI's board of directorsresponded to the offer by rejecting Raytel's bid and urging thecompany's stockholders not to tender their shares to Raytel.
MDI's board adopted two additional strategies in its defense.It established a stockholders' rights plan intended to preventRaytel or any third party from taking control of MDI without negotiatingfirst with the board to secure a deal that is fair to shareholders.It also filed a lawsuit in U.S. District Court of Delaware seekingto enjoin Raytel from carrying out its tender offer.
A hearing on the lawsuit is expected to take place in January.Meanwhile, Raytel has until Jan. 3 to complete the tender offer,although the deadline may be extended.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Study: Monitoring of Prostate MRI Exams Could Lead to 75 Percent Reduction of Gadolinium Contrast
March 17th 2025While DCE MRI was deemed helpful in over 67 percent of cases in which it was used, researchers found that monitored prostate MRI exams, which facilitated a 75 percent reduction of DCE MRI sequences, had comparable sensitivity for prostate cancer as non-monitored exams.
